Supplementary statements on news article

1.Date of occurrence of the event: 2022/02/09 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): Head office 4.Reciprocal shareholding ratios: Not applicable 5.Name of the reporting media: Economic Daily page A4, etc. 6.Content of the report: “OBI last day(Feb. 8) announced the preliminary findings of their in-house developed […]

This article is password protected.

To view the content, please enter your password in the field below